Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3, Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Safety of Repeated Administration of NurOwn (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) in Participants With ALS

Next Previous
X
Search
Trial Profile

A Phase 3, Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Safety of Repeated Administration of NurOwn (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) in Participants With ALS

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 21 Aug 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Debamestrocel (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Adverse reactions; Biomarker; Registrational; Therapeutic Use
  • Sponsors Brainstorm Cell Therapeutics

    • Most Recent Events

    • 14 Aug 2024 According to a Brainstorm media release,In May 2024, new biomarker data on NurOwn from the prior Phase 3 study and Expanded Access Program (EAP) were featured in a presentation at the 3rd Annual ALS Drug Development Summit, which took place in Boston MA.
    • 20 May 2024 According to a Brainstorm media release, Stacy Lindborg PhD will deliver a presentation on data from the Phase 3 trial. The 3rd Annual ALS Drug Development Summit, to take place May 21 to 23, 2024 in Boston MA.
    • 10 Apr 2024 Results presented in the Brainstorm Media Release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top